Talwin (pentazocine) is a small molecule pharmaceutical. Pentazocine was first approved as Talwin on 1982-01-01. It is used to treat pain in the USA. The pharmaceutical is active against sigma non-opioid intracellular receptor 1. In addition, it is known to target delta-type opioid receptor, mu-type opioid receptor, and kappa-type opioid receptor.
|Drug Class||Narcotic antagonists/agonists (6,7-benzomorphan derivatives)|